CBT for the treatment of depression in Parkinson’s disease: a promising nonpharmacological approach

References

• Arean PA, Cook BL. Psychotherapy and combined psychotherapy/pharmacotherapy for late life depression. Biol. Psychiatry52(3), 293–303 (2002).
   PubMed Web of Science ®Google Scholar
• Floyd M, Scogin F, McKendree-Smith N, Floyd DL, Rokke PD. Cognitive therapy for depression: a comparison of individual psychotherapy and bibliotherapy for depressed older adults. Behav. Modif.28(2), 297–318 (2004).
   PubMed Web of Science ®Google Scholar
• Mohr DC, Likosky W, Bertagnolli A et al. Telephone-administered cognitive–behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J. Consult. Clin. Psychol.68(2), 356–361 (2000).
   PubMed Web of Science ®Google Scholar
• Allen LA, Woolfolk RL, Gara MA, Escobar JI, Hamer R. Cognitive behavior therapy for somatization disorder. Arch. Intern. Med.166(14), 1512–1518 (2006).
   PubMed Web of Science ®Google Scholar
• Kunik ME, Braun U, Stanley MA et al. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol. Med.31(4), 717–723 (2001).
   PubMed Web of Science ®Google Scholar
• Goldstein LH, McAlpine M, Deale A et al. Cognitive behaviour therapy with adults with intractable epilepsy and psychiatric co-morbidity: preliminary observations on changes in psychological state and seizure frequency. Behav. Res. Ther.41(4), 447–460 (2003).
   PubMed Web of Science ®Google Scholar
• Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive–behavioral therapy: a review of meta-analyses. Clin. Psychol. Rev.26(1), 17–31 (2006).
   PubMed Web of Science ®Google Scholar
• DeRubeis RJ, Crits-Christoph P. Empirically supported individual and group psychological treatment for adult mental disorders. J. Consul. Clin. Psychol.66(1), 37–52 (1998).
   PubMed Web of Science ®Google Scholar
• Gloaguen V, Cottraux J, Cucherat M, Blackburn IM. A meta-analysis of the effects of cognitive therapy in depressed patients. J. Affect. Disord.49, 59–72 (1998).
   PubMed Web of Science ®Google Scholar
• Feldman G. Cognitive and behavioral therapies for depression: overview, new directions, and practical recommendations for dissemination. Psychiatr. Clin. N. Am.30, 39–50 (2007).
   PubMed Web of Science ®Google Scholar
• Keller MB, McCullough JP, Klein DN et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N. Engl. J. Med.342(20), 1462–1470 (2000).
   PubMed Web of Science ®Google Scholar
• Otto MW, Smits JAJ, Reese HE. Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: review and analysis. Clin. Psychol. Sci. Prac.12, 72–86 (2005).
   Web of Science ®Google Scholar
• DeRubeis RJ, Hollon SD, Amsterdam JD et al. Cognitive therapy versus medication in the treatment of moderate to severe depression. Arch. Gen. Psychiatry62, 409–416 (2005).
   PubMed Web of Science ®Google Scholar
• DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD. Medications versus cognitive therapy for severely depressed outpatients: mega-analysis of four randomized comparisons. Am. J. Psychiatry156(7), 1007–1013 (1999).
   PubMed Web of Science ®Google Scholar
• Dimidjian S, Hollon SD, Dobson, KS et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J. Consult. Clin. Psychol.74(4), 658–670 (2006).
   PubMed Web of Science ®Google Scholar
• Hollon SD, DeRubeis RJ, Shelton RC et al. Prevention of relapse following cognitive therapy versus medication in moderate to severe depression. Arch. Gen. Psychiatry62, 417–422 (2005).
   PubMed Web of Science ®Google Scholar
• Jost WH. Costs in the treatment of parkinsonism. J. Neurol.247(Suppl. 4), IV/31–33 (2000).
   Google Scholar
• CummingsJL. Depression and Parkinson’s disease: a review. Am. J. Psychiatry149, 443–454 (1992).
   PubMed Web of Science ®Google Scholar
• Marsh L, McDonald WM, Cummings J, Ravina B, NINDS/NIMH Work Group on Depression and Parkinson’s Disease. Provisional diagnostic criteria for depression in Parkinson’s disease: Report of an NINDS/NIMH work group. Mov. Disord.21(2), 148–158 (2006).
   PubMed Web of Science ®Google Scholar
• Richard IH, Frank S, McDermott MP et al. The ups and downs of Parkinson’s disease – a prospective study of mood and anxiety fluctuations. Cog. Behav. Neurol.17, 201–207 (2004).
   PubMedGoogle Scholar
• Menza MA, Sage J, Marshall E et al. Mood changes and “on-off” phenomena in Parkinson’s disease. Mov. Disord.5, 148–151 (1990).
   PubMed Web of Science ®Google Scholar
• Nissembaum H, Quinn NP, Brown RG et al. Mood swings associated with the “on-off” phenomenon in Parkinson’s disease. Psychol. Med.17, 899–904 (1987).
   PubMedGoogle Scholar
• Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression in Parkinson’s disease: a community-based study. Arch. Neurol.53, 175–179 (1996).
   PubMed Web of Science ®Google Scholar
• Dooneef G, Mirabello E, Bell K, Marder K, Stern Y, Mayeux R. An estimate of the incidence of depression in idiopathic Parkinson’s disease. Arch. Neurol.49, 305–307 (1992).
   PubMedGoogle Scholar
• Allain H, Schuck S, Manduit N. Depression in Parkinson’s disease. Br. Med. J.320(7245), 1287–1288 (2000).
   PubMed Web of Science ®Google Scholar
• Cummings JL, Masternan DL. Depression in patients with Parkinson’s disease. Int. J. Geriatr. Psychiatry14, 711–718 (1999).
   PubMed Web of Science ®Google Scholar
• Cole SA, Woodard JL, Juncos JL et al. Depression and disability in Parkinson’s disease. J. Neuropsychiat. Clin. Neurosci.8, 20–25 (1996).
   PubMed Web of Science ®Google Scholar
• Tandberg E, Larsen JP, Aarsland D et al. Risk factors for depression in Parkinson’s disease. Arch. Neurol.54, 625–639 (1997).
   PubMed Web of Science ®Google Scholar
• Menza MA, Mark MH. Parkinson’s disease and depression: the relationship to disability and personality. J. Neuropsychiat. Clin. Neurosci.6, 165–169 (1994).
   PubMed Web of Science ®Google Scholar
• Shiba M, Bower JH, Maraganore DM et al. Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case-control study. Mov. Disord.15(4), 669–677 (2000).
   PubMed Web of Science ®Google Scholar
• Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Recognition and treatment of depression in Parkinson’s disease. J. Geriatr. Psychiatry Neurol.16, 178–183 (2003).
   PubMed Web of Science ®Google Scholar
• The Global Parkinson’s Disease Survey (GPDS) Steering Committee. Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov. Disord.17, 60–67 (2002).
   PubMed Web of Science ®Google Scholar
• Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry69, 308–312 (2000).
   PubMed Web of Science ®Google Scholar
• Brown RG, MacCarthy B, Gotham AM et al. Depression and disability in Parkinson’s disease: a follow-up of 132 cases. Psychol. Med.18, 49–55 (1988).
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry55, 377–382 (1992).
   PubMed Web of Science ®Google Scholar
• Whetten-Goldstein K, Sloan F, Kulas E, Cutson T, Schenkman M. The burden of Parkinson’s disease on society, family, and the individual. J. Am. Geriatr. Soc.45(7), 844–849 (1997).
   PubMed Web of Science ®Google Scholar
• Klaassen T, Verhey FR, Sneijders GH, de Vet HC, van Praag H. Treatment of depression in Parkinson’s disease: a meta-analysis. J. Neuropsych. Clin. Neurosci.7, 281–286 (1995).
   PubMedGoogle Scholar
• Weintraub D, Morales KH, Moberg PJ et al. Antidepressant studies in Parkinson’s disease: a review and meta-analysis. Mov. Disord.20(9), 1161–1169 (2005).
   PubMed Web of Science ®Google Scholar
• Duvoisin RC, Sage J. Parkinson’s Disease: A Guide For Patient And Family (5th Edition). Lippincott Williams & Wilkins, PA, USA (2001).
   Google Scholar
• Kalteis K, Standhardt H, Kryspin-Exner I, Brucke T, Volc D, Alesch F. Influence of bilateral Stn-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson’s disease. J. Neural Transm.113, 1191–1206 (2005).
   PubMedGoogle Scholar
• Funkiewiez A, Ardouin C, Caputo E et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behavior in Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry75, 834–839 (2004).
   PubMed Web of Science ®Google Scholar
• Daniele A, Albanese A, Contarino MF et al. Cognitive and behavioral effects of chronic stimulation of the subthalamic nucleus in patients with Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry74, 175–182 (2003).
   PubMed Web of Science ®Google Scholar
• Berney A, Vingerhoets F, Perrin A et al. Effect on mood of subthalamic DBS for Parkinson’s disease: a consecutive series of 24 patients. Neurology59, 1427–1429 (2002).
   PubMed Web of Science ®Google Scholar
• Voon V, Saint-Cyr JA, Lozano AM, Moro E, Dujardin K, Lang AE. Suicide risk in patients with Parkinson’s disease undergoing subthalamic stimulation. Mov. Disord.19(9), S323 (2004) (Abstract P491).
   Google Scholar
• Herzog J, Reiff J, Krack P et al. Manic episode with psychotic symptoms induced by subthalamic nucleus stimulation in a patient with Parkinson’s disease. Mov. Disord.18, 1382–1384 (2003).
   PubMed Web of Science ®Google Scholar
• Kulisevsky J, Berthier ML, Gironell A, Pascual-Sedano B, Molet J, Pares P. Mania following deep brain stimulation for Parkinson’s disease. Neurology59, 1421–1424 (2002).
   PubMed Web of Science ®Google Scholar
• Romito LM, Raja M, Daniele A et al. Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson’s disease. Mov. Disord.17, 1371–1374 (2002).
   PubMed Web of Science ®Google Scholar
• Schmitz-Hubsch T, Pyfer D, Kielwein K, Fimmers R, Klockgether T, Wullner U. Qigong excerice for the symptoms of Parkinson’s disease: a randomized, controlled pilot study. Mov. Disord.21(4), 543–548 (2006).
   PubMed Web of Science ®Google Scholar
• Paus S, Schmitz-Hubsch T, Wallner U, Vogel A, Klockgether T, Abele M. Bright light therapy in Parkinson’s disease: a pilot study. Mov. Disord.22(10), 1495–1498 (2007).
   PubMed Web of Science ®Google Scholar
• Willis GL, Turner EJD. Primary and secondary features of Parkinson’s disease improve with strategic exposure to bright light: a case series study. Chronobiol. Int.24(3), 521–537 (2007).
   PubMed Web of Science ®Google Scholar
• Dreising H, Beckmann J, Wermuth L, Skovlund S, Bech P. Psychological effects of structured cognitive psychotherapy in young patients with Parkinson’s disease: a pilot study. Nordic J. Psychiatry53, 217–221 (1999).
   Google Scholar
• Dobkin RD, Allen LA, Menza M. Cognitive behavior therapy for depression in Parkinson’s disease: a pilot study. Mov. Disord.22(7), 946–952 (2007).
   PubMed Web of Science ®Google Scholar
• Cole K, Vaughan FL. Brief cognitive–behavioral therapy for depression associated with Parkinson’s disease: a single case series. Behav. Cogn Psychother.33, 89–102 (2005).
   Web of Science ®Google Scholar
• Feeney F, Egan S, Gasson N. Treatment of depression and anxiety in Parkinson’s disease: a pilot study using group cognitive behavioural therapy. Clin. Psychol.9(1), 31–38 (2005).
   Google Scholar
• Simons G, Thompson BN, Pasqualini MCS. An innovative programme for people with Parkinson’s disease and their carers. Parkinsonism Relat. Disord.12, 478–485 (2006).
   PubMed Web of Science ®Google Scholar
• Jamison PM, Welsh M, Corser C, Simmons WJ, Enguidanos SM. Results of a psychosocial needs assessment of people with PD. Mov. Disord.21(S13), S158 (2006).
   Google Scholar
• Posen J, Gilaldi N. Social work at the crossroads of Parkinson’s disease. Mov. Disord.21(S13), S158 (2006).
   Google Scholar
• Azuma T, Cruz RF, Bayles KA, Tomoeda CK, Montgomery EB. A longitudinal study of neuropsychological change in individuals with Parkinson’s disease. Int. J. Geriatr. Psychiatry18, 1115–1120 (2003).
   PubMed Web of Science ®Google Scholar
• Troster AI, Stalp LD, Paolo AM, Fields JA, Koller WC. Neuropsychological impairment in Parkinson’s disease with and without depression. Arch. Neurol.52(12), 1164–1169 (1995).
   PubMed Web of Science ®Google Scholar
• Kuzis G, Sabe L, Tiberti C, Leiguarda R, Starkstein SE. Cognitive functions in major depression and Parkinson’s disease. Arch. Neurol.54(8), 982–986 (1997).
   PubMedGoogle Scholar
• Norman S, Troster AI, Fields JA, Brooks R. Effects of depression and Parkinson’s disease on cognitive functioning. J. Neuropsychiatr. Clin. Neurosci.14, 31–36 (2002).
   PubMed Web of Science ®Google Scholar
• Troster AI, Paolo AM, Lyons KE, Glatt, SL, Huble JP, Koller WC. The influence of depression on cognition in Parkinson’s disease: a pattern of impairment distinguishable from Alzheimer’s disease. Neurology45, 672–676 (1995).
   PubMed Web of Science ®Google Scholar
• Simpson SW, Baldwin RC, Burns A, Jackson A. Regional cerebral volume measurements in late-life depression: relationship to clinical correlates, neuropsychological impairment, and response to treatment. Int. J. Geriatr. Psychiatry16, 469–476 (2001).
   PubMedGoogle Scholar
• Alexopoulos GS, Kiosses DN, Choi SJ, Murphy CF, Lim KO. Frontal white matter microstructure and treatment response to late-life depression: a preliminary study. Am. J. Psychiatry159(11), 1929–1932 (2002).
   PubMed Web of Science ®Google Scholar
• Dunkin JJ, Leuchter AF, Cook IA, Kasl-Godley JE, Abrams M, Rosenberg-Thompson S. Executive dysfunction predicts nonresponse to fluoxetine in major depression. J. Affect. Dis.60, 13–23 (2000).
   PubMed Web of Science ®Google Scholar
• Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. Guilford, NY, USA (1979).
   Google Scholar
• Goldapple K, Segal Z, Garson C et al. Modulation of cortical–limbic pathways in major depression: treatment specific effects of cognitive behavior therapy. Gen. Psychiatry61(1), 34–41 (2004).
   PubMed Web of Science ®Google Scholar
• Cole K, Vaughan FL. The feasibility of using cognitive behavior therapy for depression associated with Parkinson’s disease: a literature review. Parkinsonism Relat. Disord.11, 269–276 (2005).
   PubMed Web of Science ®Google Scholar
• Mohlman J, Gorman JM. The role of executive functioning in CBT: a pilot study with anxious older adults. Behav. Res. Ther.43(4), 447–465 (2005).
   PubMed Web of Science ®Google Scholar
• Menza MA, Rosen R. Sleep in Parkinson’s disease: the role of depression and anxiety. Psychosomatics36, 262–266 (1995).
   PubMed Web of Science ®Google Scholar
• Menza MA, Robertson-Hoffmann DE, Bonapace AS. Parkinson’s disease and anxiety: comorbidity with depression. Biol. Psychiatry34, 465–470 (1993).
   PubMed Web of Science ®Google Scholar
• Henderson R, Kurlan R, Kersun JM, Como P. Preliminary examination of the comorbidity of anxiety and depression in Parkinson’s disease. J. Neuropsychiatr. Clin. Neurosci.4, 257–264 (1992).
   PubMed Web of Science ®Google Scholar
• Schiffer RB, Kurlan R, Rubin A et al. Evidence of atypical depression in Parkinson’s disease. Am. J. Psychiatry145, 1020–1022 (1988).
   PubMed Web of Science ®Google Scholar
• Brooks DJ, Doder M. Depression in Parkinson’s disease. Curr. Opin. Neurol.14(4), 465–470 (2001).
   PubMedGoogle Scholar
• Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky RL. Linking clinical variables to health-related quality of life in Parkinson’s disease. Parkinsonism Relat. Disord.8, 199–209 (2002).
   PubMed Web of Science ®Google Scholar
• Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov. Disord.16(3), 507–510 (2002).
   Google Scholar
• Cohen S, Wills TA. Stress, social support, and the buffering hypothesis. Psychol. Bull.98(2), 310–357 (1985).
   PubMed Web of Science ®Google Scholar
• Coyne JC. Toward an interactional description of depression. Psychiatry39, 28–40 (1976).
   PubMed Web of Science ®Google Scholar
• Coyne JC, Delongis A. Going beyond support: the role of social relationships in adaptation. J. Consult. Clin. Psychol.54(4), 454–460 (1986).
   PubMed Web of Science ®Google Scholar
• Aarsland D, Larsen JP, Karlsen K, Lim NG, Tandberg E. Mental symptoms in Parkinson’s disease are important contributors to caregiver distress. Int. J. Geriatr. Psychiatry14(10), 866–874 (1999).
   PubMed Web of Science ®Google Scholar
• Tommessen B, Aarsland D, Braekhus A et al. The psychosocial burden on spouses of the elderly with stroke, dementia, and Parkinson’s disease. Int. J. Geriatr. Psychiatry17(1), 78–84 (2002).
   PubMedGoogle Scholar
• Greene SM, Griffin WA. Symptom study in context: effects of marital quality on signs of Parkinson’s disease during patient–spouse interaction. Psychiatry61(1), 35–45 (1998).
   PubMed Web of Science ®Google Scholar
• Scheurs KMG, DeRidder DTD, Bensing JM. A one-year study of coping, social support, and quality of life in Parkinson’s disease. Psychol. Health15, 109–121 (2000).
   Google Scholar
• Edwards NE, Scheetz PS. Predictors of burden for caregivers of patients with Parkinson’s disease. J. Neurosci. Nurs.34(4), 184–190 (2002).
   PubMedGoogle Scholar
• Ehmann TS, Beninger RJ, Gawel MJ, Riopelle RJ. Coping, social support, and depressive symptoms in Parkinson’s disease. J. Geriatr. Psychiatry Neurol.3(2), 85–90 (1990).
   PubMedGoogle Scholar
• MacCarthy B, Brown R. Psychosocial factors in Parkinson’s disease. Br. J. Clin. Psychol.28, 41–52 (1989).
   PubMed Web of Science ®Google Scholar
• Speer DC. Predicting Parkinson’s disease patient and caregiver adjustment: preliminary findings. Behav. Health Aging3, 139–146 (1993).
   Google Scholar
• Fleminger S. Left sided Parkinson’s disease is associated with greater anxiety and depression. Psychol. Med.21, 629–638 (1991).
   PubMed Web of Science ®Google Scholar
• Dobkin RD, Panzarella C, Fernandez J, Alloy LB, Cascardi M. Adaptive inferential feedback, depressogenic inferences, and depressed mood: a laboratory study of the expanded hopelessness theory of depression. Cogn Ther. Res.28(4), 487–509 (2004).
   Google Scholar
• Alloy LB, Abramson LY, Tashman NA et al. Developmental origins of cognitive vulnerability to depression: parenting, cognitive, and inferential feedback styles of the parents of individuals at high and low cognitive risk for depression. Cogn Ther. Res.25 (4), 397–423 (2001).
   Web of Science ®Google Scholar
• Lewinsohn PM, Munoz RF, Youngren MA, Zeiss AM. Control Over Depression (2nd Edition). Prentice Hall, Englewood Cliffs, NJ, USA (1986).
   Google Scholar
• Leahy RL, Holland SJ. Treatment Plans and Interventions for Depression and Anxiety Disorders. Guilford Publications, NY, USA (2000).
   Google Scholar